Abstract
Context:Clinical sequelae of androgen deficiency share common features with frailty. Evidence supporting the role of androgens in the development of frailty is limited and conflicting.Objective:To determine associations between male reproductive hormones and prospective changes in frailty status.Design/Setting:A 4.3-year prospective cohort study of community-dwelling men participating in the European Male Ageing Study.Participants:A total of 3369 men aged 40 to 79 from eight European centers.Intervention:None.Main Outcome Measure:Frailty status was determined using frailty index (FI; n = 2278) and frailty phenotype (FP; n = 1980).Results:After adjusting for baseline frailty, age, center, and smoking, the risk of worsening FI decreased with higher testosterone (T), free T, and dihydrotestosterone (DHT) [percentage change (95% confidence interval) in FI associated with 1 standard deviation higher hormone level: –3.0 (–5.9, –1.0) for total T; –3.9 (–6.8, –2.0) for free T; and –3.9 (–6.8, –2.0) for DHT]. After further adjustment for body mass index, only free T remained a significant predictor of FI change. In fully adjusted models, higher luteinizing hormone and follicle-stimulating hormone were positively related to worsening FI only in men <60 years, and higher estradiol predicted lower likelihood of improving FP [odds ratio: 0.68 (0.52, 0.88)].Conclusions:These prospective data support the hypothesis that higher androgen levels may protect elderly men from worsening frailty. However, the causal nature of these relationships requires further investigation. Whereas raised gonadotropins in men <60 years might be an early marker of frailty, the role of estradiol in frailty needs further clarification.
Highlights
University, Complejo Hospitalario Universitario de Santiago, CIBER de Fisiopatologıa Obesidad y Nutricion, Instituto Salud Carlos III, Santiago de Compostela 15706, Spain; 5Sexual Medicine and Andrology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio,” University of Florence, Florence 50139, Italy; 6Reproductive Medicine Centre, Malmo University Hospital, University of Lund, SE-221 00 Lund, Sweden; 7Institute of Cardiovascular Research, Royal Holloway University of London, Egham TW20 0EX, United Kingdom; 8Ashford and St
After adjusting for baseline frailty, age, center, and smoking, the risk of worsening frailty index (FI) decreased with higher testosterone (T), free T, and dihydrotestosterone (DHT) [percentage change (95% confidence interval) in FI associated with 1 standard deviation higher hormone level: –3.0 (–5.9, –1.0) for total T; –3.9 (–6.8, –2.0) for free T; and –3.9 (–6.8, –2.0) for DHT]
Frailty in the elderly describes a state of reduced homeostatic reserve and diminished resistance to external and internal stressors, which is associated with adverse outcomes such as disability, falls, and death [1, 2]
Summary
Evidence supporting the role of androgens in the development of frailty is limited and conflicting
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call